An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes

INTRODUCTION: To date, there have been few head-to-head comparisons between semaglutide once-weekly (OW) and short-acting meal-time insulin in participants with type 2 diabetes (T2D) treated with basal insulin and requiring treatment intensification. This indirect comparison evaluated the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingvay, Ildiko, Catarig, Andrei-Mircea, Lawson, Jack, Chubb, Barrie, Gorst-Rasmussen, Anders, Evans, Lyndon Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880115/
https://www.ncbi.nlm.nih.gov/pubmed/36434159
http://dx.doi.org/10.1007/s13300-022-01344-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880115/
https://www.ncbi.nlm.nih.gov/pubmed/36434159
http://dx.doi.org/10.1007/s13300-022-01344-7

Ejemplares similares